ISO TS 22693-2021 PDF

ISO TS 22693-2021 PDF

Genomics informatics-Structured clinical gene fusion report in electronic health records

$96.50 $193.00 -50%
Product Code: ISO TS 22693
Stock In Stock
Edition: 1ST
Published: 06/2021
Number of Pages: 28
File Size: 1 file, 1 Byte

Available Options

Product Description

Genomics informatics — Structured clinical gene fusion report in electronic health records

Introduction: With the rapid advancement of next generation sequencing technologies, clinical sequencing has been applied to realize precision medicine. ISO/TS 20428[1] aims at standardizing the clinical sequencing reports in electronic health records but focuses on only DNA variations. However, the importance of transcriptome information has been increased. The transcriptome is the complete set of all messenger RNA molecules, which encode for the amino acid sequence of proteins. RNA sequencing gives us a large amount of information on gene expression and RNA alterations in disease status. From a molecular diagnostic standpoint, RNA-based measurements have the potential for broad application across diverse areas of human health, including disease diagnosis, prognosis, and therapeutic selection. A fusion gene is a hybrid gene made by the combination of two or more genes that had previously existed independently. It is known to occur due to structural abnormalities of chromosomes such as insertion, deletion, translocation, and inversion. Fluorescence in situ hybridization (FISH) has been used as a gold standard as a method of detecting gene fusion in clinical practice but advances in technology have enabled RNA-based detection of fusion genes that directly affect protein coding. One of the most widely applied RNA-based technologies is qRT-PCR (Quantitative Reverse Transcription-Polymerase Chain Reaction). The relatively inexpensive NGS (Next generation sequencing) method is actively used in

Scope: The document defines the data elements and their necessary metadata to implement a structured clinical gene fusion report whose data are generated by next generation sequencing technologies. This document — describes the reporting guideline for RNA sequencing approaches focusing on detecting novel and known fusion partners, — defines the required data fields and their metadata for a structured clinical gene fusion report, — defines the optional data fields and their metadata, — covers the fusion gene from human specimen using whole transcriptome sequencing by next generation sequencing technologies for clinical practice and translational research, — does not cover the fusion gene detection using DNA sequencing methods, — does not cover the basic research and other scientific areas, — does not cover the other biological species, — does not cover the Sanger sequencing methods, and — does not cover the other structural variations. This document only defines the data elements and their metadata for the structured clinical sequencing report in electronic health records. Therefore, its layout can be designed based on the institutional decision if all elements are included as in this document.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
ISO TS 22693-2021 PDF

ISO TS 22693-2021 PDF

$96.50 $193.00